Oxidation of the lignan nordihydroguaiaretic acid

Chemical Research in Toxicology

Volumn 20, Issue 9, 2007, Pages 1352-1358

  Billinsky, Jennifer L ^a   Marcoux, Michelle R ^a   Krol, Ed S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE DERIVATIVE; LIGNAN; NORDIHYDROGUAIARETIC ACID; QUINONE DERIVATIVE;

ARTICLE; AUTOOXIDATION; CATALYSIS; DRUG METABOLISM; DRUG OXIDATION; ENZYME CHEMISTRY; INCUBATION TIME; LIVER MICROSOME METABOLISM; METABOLITE; NONHUMAN; OXIDATION KINETICS; PH; RAT; TOXICITY TESTING; TOXICOKINETICS;

ANIMALS; HYDROGEN-ION CONCENTRATION; LIGNANS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOLECULAR STRUCTURE; NORDIHYDROGUAIARETIC ACID; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; WATER;

RATTUS;

EID: 35148843866     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700205j     Document Type: Article

References (59)

1. Arteaga, S., Andrade-Cetto, A., and Cardenas, R. (2005) Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J. Ethnopharmacol. 98, 231-239.
2. Tong, W., Ding, X., and Adrian, T. E. (2002) The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 296, 942-948.
3. Yasumoto, K., Yamamoto, A., and Mitsuda, H. (1970) Studies on Soybean Lipoxygenase. 4. Effect of Phenolic Antioxidants on Lipoxygenase Reaction. Agric. Biol. Chem. 34, 1162-1168.
4. Gonzales, M., and Bowden, G. T. (2002) Nordihydroguaiaretic acid-mediated inhibition of ultraviolet B-induced activator protein-1 activation in human keratinocytes. Mol. Carcinog. 34, 102-111.
5. Martin, M. E., Haourigui, M., Pelissero, C., Benassayag, C., and Nunez, E. A. (1996) Interactions between phytoestrogens and human sex steroid binding protein. Life Sci. 58, 429-436.
6. Wong, W. S., and McLean, A. E. M. (1999) Effects of phenolic antioxidants and flavonoids on DNA synthesis in rat liver, spleen, and testis in vitro. Toxicology 139, 243-253.
7. Naiki, H., Hasegawa, K., Yamaguchi, I., Nakamura, H., Gejyo, F., and Nakakuki, K. (1998) Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 37, 17882-17889.
8. 2+-ATPase by nordihydroguaiaretic acid. Mol. Cell. Biochem. 195, 227-233.
9. Agarwal, R., Wang, Z. Y., Bik, D. P., and Mukhtar, H. (1991) Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab. Dispos. 19, 620-624.
10. Athar, M., Raza, H., Bickers, D. R., and Mukhtar, H. (1990) Inhibition of benzoyl peroxide-mediated tumor promotion in 7,12-dimethylbenz (a)anthracene-initiated skin of Sencar mice by antioxidants nordihydroguaiaretic acid and diallyl sulfide. J. Invest. Dermatol. 94, 162-165.
11. Moody, T. W., Leyton, J., Martinez, A., Hong, S., Malkinson, A., and Mulshine, J. L. (1998) Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp. Lung Res. 24, 617-628.
12. Nakadate, T., Yamamoto, S., Aizu, E., and Kate, R. (1989) Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice. Carcinogenesis 10, 2053-2057.
13. Nakamura, M., Nakazawa, J., Usui, T., Osada, H., Kono, Y., and Takatsuki, A. (2003) Nordihydroguaiaretic acid, of a new family of microtubule-stabilizing agents, shows effects differentiated from paclitaxel. Biosci. Biotechnol. Biochem. 67, 151-157.
14. Madrigal-Bujaidar, E., Barriga, S. D., Cassani, M., Marquez, P., and Revuelta, P. (1998) In vivo and in vitro antigenotoxic effect of nordihydroguaiaretic acid against SCEs induced by methyl methanesulfonate. Mutat. Res. 419, 163-168.
15. Barriga, S. D., Madrigal-Bujaidar, E., and Márquez, P. (1999) Inhibitory effect of nordihydroguaiaretic acid on the frequency of micronuclei induced by methyl methanesulfonate in vivo. Mutat. Res. 441, 53-58.
16. Biswal, S. S., Datta, K., Shaw, S. D., Feng, X., Robertson, J. D., and Kehrer, J. P. (2000) Glutathione oxidation and mitochondrial depolarization as mechanisms of nordihydroguaiaretic acid-induced apoptosis in lipoxygenase-deficient FL5.12 cells. Toxicol. Sci. 53, 77-83.
17. Deshpande, V. S., and Kehrer, J. P. (2006) Oxidative stress-driven mechanisms of nordihydroguaiaretic acid-induced apoptosis in FL5.12 cells. Toxicol. Appl. Pharmacol. 214, 230-236.
18. Fujimoto, N., Kohta, R., Kitamura, S., and Honda, H. (2004) Estrogenic activity of an antioxidant, nordihydroguaiaretic acid (NDGA). Life Sci. 74, 1417-1425.
19. Lundberg, W. O., Halvorson, H. O., and Burr, G. O. (1944) The antioxidant properties of nordihydroguaiaretic acid. Oil Soap 21, 33-35.
20. Oliveto, E. P. (1972) Nordihydroguaiaretic acid. A naturally occurring antioxidant. Chem. Ind. 17, 677-679.
21. Ramasamy, S., Drummond, G. R., Ahn, J., Storek, M., Pohl, J., Parthasarathy, S., and Harrison, D. G. (1999) Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells. Mol. Pharmacol. 56, 116-123.
22. Kelly, M. R., Xu, J., Alexander, K. E., and Loo, G. (2001) Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutat. Res. 485, 309-318.
23. Harper, A., Kerr, D. J., Gescher, A., and Chipman, J. K. (1999) Antioxidant effects of isoflavonoids and lignans, and protection against DNA oxidation. Free Radical Res. 31, 149-160.
24. Koob, T. J. (2002) Biomimetic approaches to tendon repair. Comp. Biochem. Physiol. A 133, 1171-1192.
25. Gooman, T., Grice, H. C., Becking, G. C., and Salem, F. A. (1970) A cystic neuropathy induced by nordihydroguaiaretic acid in the rat. Lab. Invest. 23, 93-107.
26. Grice, H. C., Becking, G., and Gooman, T. (1968) Toxic properties of nordihydroguaiaretic acid. Food Cosmet. Toxicol. 6, 155-161.
27. Lambert, J. D., Zhao, D., Meyers, R. O., Kuester, R. K., Timmermann, B. N., and Dorr, R. T. (2002) Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse. Toxicon 40, 1701-1708.
28. Gordon, D. W., Rosenthal, G., Hart, J., Sirota, R., and Baker, A. L. (1995) Chaparral ingestion: The broadening spectrum of liver injury caused by herbal medications. J. Am. Med. Assoc. 273, 489-490.
29. Koff, R. S. (1995) Herbal hepatotoxicity: Revisiting a dangerous alternative. J. Am. Med. Assoc. 273, 502.
30. Batchelor, W. B., Heathcote, J., and Wanless, I. R. (1995) Chaparral-induced hepatic injury. Am. J. Gastroenterol. 90, 831-833.
31. Katz, M., and Saibil, F. (1990) Herbal hapaptitis: subacute hepatic necrosis secondary to chaparral leaf. J. Clin. Gastroenterol. 12, 203-206.
32. Clark, F., and Reed, R. (1992) Chaparral-induced toxic hepatitis-California and Texas, 1992. J. Am. Med. Assoc. 268, 3295-3296.
33. Wagner, P., and Lewis, R. A. (1980) Interaction between activated nordihydroguaiaretic acid and deoxyribonucleic acid. Biochem. Pharmacol. 29, 3299-3306.
34. Bolton, J. L., Acay, N. M., and Vukomanovic, V. (1994) Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole. Chem. Res. Toxicol. 7, 443-450.
35. Iverson, S. L., Hu, L. Q., Vukomanovic, V., and Bolton, J. L. (1995) The influence of the p-alkyl substituent on the isomerization of o-quinones to p-quinone methides: potential bioactivation mechanism for catechols. Chem. Res. Toxicol. 8, 537-544.
36. Thompson, D. C., Thompson, J. A., Sugumaran, M., and Moldeus, P. (1993) Biological and toxicological consequences of quinone methide formation. Chem.-Biol. Interact. 86, 129-162.
37. Chichirau, A., Flueraru, M., Chepelev, L. L., Wright, J. S., Willmore, W. G., Durst, T., Hussain, H. H., and Charron, M. (2005) Mechanism of cytotoxicity of catechols and a naphthalenediol in PC12-AC cells: the connection between extracellular autoxidation and molecular electronic structure. Free Radical Biol. Med. 38, 344-355.
38. Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., and Graham, D. G. (1992) Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 112, 2-16.
39. O'Brien, P. J. (1991) Molecular mechanisms of quinone cytotoxicity. Chem.-Biol. Interact. 80, 1-41.
40. Powis, G. (1987) Metabolism and reactions of quinoid anticancer agents. Pharmacol. Ther. 35, 57-162.
41. Bolton, J. L., Pisha, E., Shen, L., Krol, E. S., Iverson, S. L., Huang, Z., van Breemen, R. B., and Pezzuto, J. M. (1997) The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkycatechol-induced toxicity in human melanoma cells. Chem.-Biol. Interact. 106, 133-148.
42. Jordan, R. T., and Allen, L. M. (1988) Pharmacologically active compositions of catecholic butanes with zinc. WO8801509, pp. 1-143.
43. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265.
44. Omura, T., and Sato, R. (1964) The carbon-monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 239, 2379-2385.
45. Petrin, D. D. and Dempsey, B. (1974) Buffers for pH and Metal Ion Control. Wiley, New York.
46. Shen, L., Qiu, S., van Breemen, R. B., Zhang, F., Chen, Y., and Bolton, J. L. (1997) Reaction of the premarin metabolite 4-hydroxyequilenin semiquinone radical with 2′-deoxyguanosine: formation of unusual cyclic adducts. J. Am. Chem. Soc. 119, 11126-11127.
47. Potter, D. W., Miller, D. W., and Hinson, J. A. (1986) Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione. Mol. Pharmacol. 29, 155-162.
48. Potter, D. W., Miller, D. W., and Hinson, J. A. (1985) Identification of acetaminophen polymerization products catalyzed by horseradish peroxidase. J. Biol. Chem. 260, 12174-12180.
49. Koob, T. J., and Hernandez, D. J. (2002) Material properties of polymerized NDGA-collagen composite fibers: development of biologically based tendon constructs. Biomaterials 23, 203-212.
50. Herlinger, E., Jameson, R. F., and Linert, W. (1995) Spontaneous autoxidation of dopamine. J. Chem. Soc., Perkin Trans. 1, 259-263.
51. Rinaldi, A. C., Porcu, M. C., Curreli, N., Rescigno, A., Finazzi-Agró, A., Pedersen, J. Z., Rinaldi, A., and Sanjust, E. (1995) Autoxidation of 4-methylcatechol: a model for the study of biosynthesis of copper amine oxidases quinoid cofactor. Biochem. Biophys. Res. Commun. 214, 559-567.
52. Shen, L., Pisha, E., Huang, Z., Pezzuto, J. M., Krol, E. S., Alam, Z., van Breemen, R. B., and Bolton, J. L. (1997) Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinone formation and reactivity. Carcinogenesis 18, 1093-1101.
53. Joslyn, M. A., and Branch, G. E. K. (1935) The kinetics of absorption of oxygen by catechol. J. Am. Chem. Soc. 57, 1779-1785.
54. Roginsky, V., and Alegria, A. E. (2005) Oxidation of tea extracts and tea catechins by molecular oxygen. J. Agric. Food Chem. 53, 4529-4535.
55. Schusler-van Hees, M. T., Beijersbergen van Henegouwen, G. M., and Stoutenberg, P. (1985) Autoxidation of catechol(amine)s. Pharm. Weekbl. Sci. 7, 245-251.
56. Nebot, C., Moutet, M., Huet, P., Xu, J. Z., Yadan, J. C., and Chaudiere, J. (1993) Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal. Biochem. 214, 442-451.
57. Moridani, M. Y., Siraki, A., Chevaldina, T., Scobie, H., and O'Brien, P. J. (2004) Quantitative structure toxicity relationships for catechols in isolated rat hepatocytes. Chem.-Biol. Interact. 147, 297-307.
58. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A. (2004) Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17, 3-16.
59. Ju, C., and Uetrecht, J. P. (2002) Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. Curr. Drug Metab. 3, 367-377.